Vaccines and Toxoids: 2018 and 2019 Changes (November 2018)

Why This Topic Matters

Vaccine coding changes can affect charge capture, claim reporting, and system updates across CPT release cycles. Understanding which vaccine product codes were added or revised and how the CPT update process is described helps organizations keep coding references current.

Article Sections

1. CPT 2018 Code Set Changes

   Summarizes the 2018 updates in the Medicine/Vaccines, Toxoids subsection of CPT. The section covers newly established and revised vaccine product codes, symbol status changes, and resequencing notes.

2. Vaccines, Toxoids

   Provides the vaccine product update discussion for 2018 and 2019 in the CPT vaccines and toxoids area. The section addresses multiple vaccine categories and the related editorial updates described in the article.

3. CPT 2019 Code Set Changes

   Introduces the 2019 vaccine code update in the same CPT subsection. The section notes the addition of a new vaccine product code and the surrounding publication context.

4. FDA Vaccine Licensure Update

   Explains how FDA approval-pending symbol status was addressed for selected vaccine product codes. The section also describes the broader CPT handling of early-release vaccine products and status tracking.

5. Where to Find Vaccine Updates

   Describes where CPT vaccine update information is made available and how release timing is presented. The section covers the general update process and implementation period language for vaccine product codes.